AzTrials
AzTrials

Healthy WomenAP-Pro-FemNCT06746220

Effect of Physical Activity and/or Probiotics on Body Composition and Physiological Parameters in Women

A study testing Microbiota sample, Salivary sample and Quality of life questionnaires in people with Healthy Women, run by Centre Hospitalier Régional d'Orléans at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is a prospective, comparative, double-blind, randomized, monocentric study. The objective of this project is to evaluate the effects on health of probiotic supplementation (PS) with or without physical activity (PA). Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Healthy Women
What is being tested?
Microbiota sample, Salivary sample and Quality of life questionnaires
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
120 participants
Where
1 siteFrance
Study dates
16 Sep 2024to 15 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Being female
  • Age ≥ 18 years old
  • Have a BMI between 18.5 and 30 kg/m2
  • Be registered as a student at the University of Orléans
  • Be non-athletic
  • Have no contraindication to the practice of physical activity
  • All participants must sign informed consent before the start of the study

Who cannot join

  • Smokers >10 cigarettes per day
  • Having treatment for a pathology at the time of inclusion
  • Taking a probiotic supplement during the last month prior to inclusion
  • Practice physical activity regularly (150 minutes/week of moderate physical activity according to the WHO)
  • Participant under guardianship or curators
  • Pregnant or breastfeeding women
  • Menopausal women
  • Allergy to any excipient known to be present in the probiotic or placebo formulation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Center Hospitalier Universitaire d'Orléans

    Orléans, 45067

    Virgile AMIOT, Doctor, 0238514785 ext. +33, virgile.amiot@chu-orleans.fr

    Recruiting

Other trials in France

About this study

This is a prospective, comparative, double-blind, randomized, monocentric study.

The objective of this project is to evaluate the effects on health of probiotic supplementation (PS) with or without physical activity (PA). Participants who meet the study criteria will be randomized into 4 groups: probiotic and physical activity group (A+), probiotic and non-physical activity group (A-), placebo and physical activity group (T+), placebo and non-physical activity group (T-).

Read more

The probiotics used are Lactibiane® Reference provided by Pileje Laboratory. The study population are healthy women (university students) who do not practice sports. A total of 120 participants will participate.

At inclusion, each participant will undergo a medical examination, collect microbiota and salivary samples and perform different tests (questionnaires, assessments of strength and endurance). Then, a follow up phase will last 6 weeks. Each participant will receive a pillbox containing capsules (probiotic or placebo in a double-blind manner). Participants which randomized in the PA groups (A+ and A-) will perform 2 physical activity sessions per week for 6 weeks. At the end of this follow up phase, tests conducting during inclusion will be performed again.

Read the detailed description

Rationale: Nowadays, the intestinal microbiota is recognized as a significant factor in the health of the host organism. It has an impact on the immune system, the hypothalamo-hypophyseal adrenal axis, the overall state of the individual such as body composition and muscle activity. The intestinal microbiota has also an impact on digestion and associated problems. However, its balance is fragile and can be easily disrupted by a diet rich in proteins or carbohydrates, medications, contraceptive use or lack of physical activity (PA).To restore this balance, subjects may modify their diet, take probiotic supplements (PS) or engage in physical activity. Currently, studies remain limited, particularly regarding effects of physical activity and/or probiotic have never been explored especially in women. The objective of this project is therefore to explore effects of PS and/or PA on the mental and physical health of the holobiont.

Method: Each participant will, during an initial visit, undergo a medical examination (ECG, anthropometric measurements) to ensure there are no contraindications to engaging in physical activity or taking probiotics. Then, we will conduct the first collections of intestinal microbiota and salivary cortisol, initial evaluations of anxiety, depression, and self-esteem (indicators of mental health with questionnaires), as well as assessments of strength and endurance (indicators of physical health), body composition, and nutritional parameters. Following this, participants will be assigned to experimental groups, and we will distribute pillboxes containing capsules (probiotic or placebo in a double-blind manner). Participants in the PA groups (A+ and A-) will perform two 45-minute physical activity sessions per week for 6 weeks, consisting of muscle strengthening and endurance exercises. Participants in the sedentary groups (T+ and T-) will be contacted by phone once a week to ensure proper protocol adherence. At the end of the 6 weeks, we will repeat the tests conducted during the initial visit.

Probiotics: The probiotics used are Lactibiane® Reference, composed of 4 probiotic strains (Bifidobacterium longum LA101, Lactobacillus helveticus LA102, Lactobacillus lactis LA103, Streptococcus thermophilus LA104) dosed at 10 billion per capsule provided by Pileje laboratory. Placebos are also provided by Pileje laboratory.

Statistics: Having no proven hypothesis on the effect of physical activity and/or probiotic supplementation on the population, we started with inclusion of 120 participants in total. This will allow to highlight a moderate effect size (0.25) for the primary endpoint, under the hypothesis of an alpha risk of 0.05, with a power of 80%. and representing 20% lost to follow-up.

Conditions
Healthy Women
Being tested
Microbiota sample, Salivary sample, Quality of life questionnaires, Nutritional evaluation, Assessment of physical health
Keywords
Microbiota, Probiotics, Physical activity, Health, women
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Microbiota sampleOther

    Microbiota sample: one sample at inclusion and one sample at the end of the study

  • Salivary sampleOther

    Salivary sample: one sample at inclusion and one sample at the end of the study. In the morning, on an empty stomach.

  • Quality of life questionnairesOther

    Quality of life questionnaires: 5 auto-questionnaires to be filled at inclusion and at the end of the study

  • Nutritional evaluationOther

    Nutritional evaluation: food diary completed by participants for 3 consecutive days at inclusion and at the end of the study

  • Assessment of physical healthOther

    Assessment of physical health : 3 tests to assess strength and endurance. These tests will be performed at inclusion and at the end of the study.

  • Physical activityOther

    Physical activity: 2 sessions per week for 6 weeks. For each session, 45 minutes of physical activity consisting of muscle strengthening and endurance exercises.

  • Treatment with placebo or probioticOther

    Treatment with placebo or probiotic: 1 capsule per day during 42 consecutive days. In the morning, on an empty stomach with a large glass of water 20 minutes before the meal

Study groups in NCT06746220
Study groupRoleWhat they receive
A+ group (probiotic and physical activity)ExperimentalMicrobiota sample Salivary sample Quality of life questionnaires Nutritional evaluation Assessment of physical health Physical activity Treatment with placebo or probiotic
Receives: Other: Microbiota sample; Other: Salivary sample; Other: Quality of life questionnaires; Other: Nutritional evaluation; Other: Assessment of physical health; Other: Physical activity; Other: Treatment with placebo or probiotic
A- group (probiotic and non-physical activity)ExperimentalMicrobiota sample Salivary sample Quality of life questionnaires Nutritional evaluation Assessment of physical health Physical activity Treatment with placebo or probiotic
Receives: Other: Microbiota sample; Other: Salivary sample; Other: Quality of life questionnaires; Other: Nutritional evaluation; Other: Assessment of physical health; Other: Physical activity; Other: Treatment with placebo or probiotic
T+ group (placebo and physical activity)ExperimentalMicrobiota sample Salivary sample Quality of life questionnaires Nutritional evaluation Assessment of physical health Physical activity Treatment with placebo or probiotic
Receives: Other: Microbiota sample; Other: Salivary sample; Other: Quality of life questionnaires; Other: Nutritional evaluation; Other: Assessment of physical health; Other: Treatment with placebo or probiotic
T- group (placebo and non-physical activity)ExperimentalMicrobiota sample Salivary sample Quality of life questionnaires Nutritional evaluation Assessment of physical health Physical activity Treatment with placebo or probiotic
Receives: Other: Microbiota sample; Other: Salivary sample; Other: Quality of life questionnaires; Other: Nutritional evaluation; Other: Assessment of physical health; Other: Treatment with placebo or probiotic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effect of physical activity on muscle mass in healthy women

    Assessment of muscle mass with an impedance meter

    Measured: Measure of muscle mass will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  2. Effect of probiotic supplementation on muscle mass in healthy women

    Assessment of muscle mass with an impedance meter

    Measured: Measure of muscle mass will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

Secondary outcomes (25)
  1. Effect of physical activity on physical condition

    Test for endurance

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  2. Effect of physical activity on physical condition

    Test for upper limb (grip strength)

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  3. Effect of physical activity on physical condition

    Test for lower limb (horizontal press test)

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  4. Effect of probiotic supplementation on physical condition

    Test for upper limb (grip strength)

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  5. Effect of probiotic supplementation on physical condition

    Test for lower limb (horizontal press test)

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  6. Effect of probiotic supplementation on physical condition

    Test for endurance

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  7. Effect of physical activity on eating behavior

    Eating behavior: food diary completed by participants for 3 consecutive days. Using specific software (nutrilog), analysis of quantitative energy intake (macronutrients and micronutrients)

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  8. Effect of probiotic supplementation on eating behavior

    Eating behavior: food diary completed by participants for 3 consecutive days. Using specific software (nutrilog), analysis of quantitative energy intake (macronutrients and micronutrients)

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  9. effect of prebiotics naturally present in food on the composition of the microbiota

    effect of prebiotics: food diary completed by participants for 3 consecutive days. Using specific software (nutrilog), analysis of the content of foods rich in prebiotics (foods rich in fiber) in the diet.

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  10. Effect of physical activity on microbiota

    Microbiota: samples of stool with specific kit (MT0001G Gut Alive). Identify bacterial composition with 16S RNA sequencing

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  11. Effect of probiotic supplementation on microbiota

    Microbiota: samples of stool with specific kit (MT0001G Gut Alive). Identify bacterial composition with 16S RNA sequencing

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  12. . Effect of physical activity on salivary cortisol

    Salivary cortisol: samples of saliva with specific kit ("salitubes"). Free fraction of cortisol will be analysed by Enzyme-linked immunosorbent assays (ELISA)

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  13. . Effect of probiotic supplementation on salivary cortisol

    Salivary cortisol: samples of saliva with specific kit ("salitubes"). Free fraction of cortisol will be analysed by Enzyme-linked immunosorbent assays (ELISA)

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  14. . Effect of physical activity on quality of life

    Quality of life with MOS-SF36 questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  15. . Effect of physical activity on quality of life

    Anxiety, depression with HAD questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  16. . Effect of physical activity on quality of life

    Self-esteem with ISP-25 questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  17. . Effect of physical activity on quality of life

    Effects of dietary supplement with EPCA questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  18. . Effect of physical activity on quality of life

    Daily physical activity with IPAQ questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  19. Effect of probiotic supplementation on quality of life

    Quality of life with MOS-SF36 questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  20. Effect of probiotic supplementation on quality of life

    Anxiety, depression with HAD questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  21. Effect of probiotic supplementation on quality of life

    Self-esteem with ISP-25 questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  22. Effect of probiotic supplementation on quality of life

    Effects of dietary supplement with EPCA questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  23. Effect of probiotic supplementation on quality of life

    Daily physical activity with IPAQ questionnaire

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  24. Effect of physical activity on fat mass

    Fat mass: assessment of fat mass with an impedance meter

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

  25. Effect of probiotic supplementation on fat mass

    Fat mass: assessment of fat mass with an impedance meter

    Measured: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2024
  2. Study start16 Sep 2024
  3. Primary completion15 Sep 2027 (estimated)
  4. Study completion15 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a prospective, comparative, double-blind, randomized, monocentric study to explore effects of PA and/or PS on healthy women.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06746220
Sponsor's protocol ID
CHUO-2024-01
Acronym
AP-Pro-Fem
Status last verified
Dec 2025
First submitted
4 Sep 2024
Last updated
30 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Abenavoli L, Scarpellini E, Colica C, Boccuto L, Salehi B, Sharifi-Rad J, Aiello V, Romano B, De Lorenzo A, Izzo AA, Capasso R. Gut Microbiota and Obesity: A Role for Probiotics. Nutrients. 2019 Nov 7;11(11):2690. doi: 10.3390/nu11112690.

    PubMed 31703257
  • Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA, Holscher HD, Woods JA. Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans. Med Sci Sports Exerc. 2018 Apr;50(4):747-757. doi: 10.1249/MSS.0000000000001495.

    PubMed 29166320
  • Alvarez-Arrano V, Martin-Pelaez S. Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systematic Review. Nutrients. 2021 Oct 17;13(10):3627. doi: 10.3390/nu13103627.

    PubMed 34684633
  • Aya V, Florez A, Perez L, Ramirez JD. Association between physical activity and changes in intestinal microbiota composition: A systematic review. PLoS One. 2021 Feb 25;16(2):e0247039. doi: 10.1371/journal.pone.0247039. eCollection 2021.

    PubMed 33630874
  • Aya V, Jimenez P, Munoz E, Ramirez JD. Effects of exercise and physical activity on gut microbiota composition and function in older adults: a systematic review. BMC Geriatr. 2023 Jun 12;23(1):364. doi: 10.1186/s12877-023-04066-y.

    PubMed 37308839
  • Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 2012 Jan;7(1):91-109. doi: 10.2217/fmb.11.142.

    PubMed 22191449
  • Bastianelli C, Farris M, Bianchi P, Benagiano G. The effect of different contraceptive methods on the vaginal microbiome. Expert Rev Clin Pharmacol. 2021 Jul;14(7):821-836. doi: 10.1080/17512433.2021.1917373. Epub 2021 Apr 23.

    PubMed 33863265
  • Boisseau N, Barnich N, Koechlin-Ramonatxo C. The Nutrition-Microbiota-Physical Activity Triad: An Inspiring New Concept for Health and Sports Performance. Nutrients. 2022 Feb 22;14(5):924. doi: 10.3390/nu14050924.

    PubMed 35267899

Questions about this trial

What is this clinical trial studying?

A study testing Microbiota sample, Salivary sample and Quality of life questionnaires in people with Healthy Women, run by Centre Hospitalier Régional d'Orléans at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Virgile AMIOT, Doctor (0238514785 ext. +33, virgile.amiot@chu-orleans.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effect of physical activity on muscle mass in healthy women (time frame: Measure of muscle mass will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06746220, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in